Back to Browse Journals » Neuropsychiatric Disease and Treatment » Volume 13

Neuropsychiatric Disease and Treatment


Archive: Volume 13, 2017

Trichotillomania: the impact of treatment history on the outcome of an Internet-based intervention

Weidt S, Bruhl AB, Delsignore A, Zai G, Kuenburg A, Klaghofer R, Rufer M

Neuropsychiatric Disease and Treatment 2017, 13:1153-1162

Published Date: 21 April 2017

Plasma concentrations and dosing of 2 long-acting injectable formulations of aripiprazole

Salzman PM, Raoufinia A, Legacy S, Such P, Eramo A

Neuropsychiatric Disease and Treatment 2017, 13:1125-1129

Published Date: 20 April 2017

Long-term effect of galantamine on cognitive function in patients with Alzheimer’s disease versus a simulated disease trajectory: an observational study in the clinical setting

Nakagawa R, Ohnishi T, Kobayashi H, Yamaoka T, Yajima T, Tanimura A, Kato T, Yoshizawa K

Neuropsychiatric Disease and Treatment 2017, 13:1115-1124

Published Date: 19 April 2017

Perceived parental affectionless control is associated with high neuroticism

Takahashi N, Suzuki A, Matsumoto Y, Shirata T, Otani K

Neuropsychiatric Disease and Treatment 2017, 13:1111-1114

Published Date: 18 April 2017

Levodopa-responsive depression associated with corticobasal degeneration: a case report

Tarakita N, Nishijima H, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2017, 13:1107-1110

Published Date: 18 April 2017

Psychosis in behavioral variant frontotemporal dementia

Gossink FT, Vijverberg EGB, Krudop W, Scheltens P, Stek ML, Pijnenburg YAL, Dols A

Neuropsychiatric Disease and Treatment 2017, 13:1099-1106

Published Date: 13 April 2017

Treatment satisfaction with paliperidone extended-release tablets: open-label study in schizophrenia patients dissatisfied with previous antipsychotic medication

Yang FD, Li J, Tan YL, Liang WY, Zhang R, Wang N, Feng W, Cai S, Zhuo JM, Zhang LL

Neuropsychiatric Disease and Treatment 2017, 13:1089-1097

Published Date: 13 April 2017

Tumor necrosis factor-α and -β genetic polymorphisms as a risk factor in Saudi patients with schizophrenia

Kadasah S, Arfin M, Rizvi S, Al-Asmari M, Al-Asmari A

Neuropsychiatric Disease and Treatment 2017, 13:1081-1088

Published Date: 12 April 2017

Are psychiatric comorbidities and associated cognitive functions related to treatment response to methylphenidate in boys with attention-deficit/hyperactivity disorder?

Chan MH, Leung PW, Ho TP, Hung SF, Lee CC, Tang CP, Cheung KC, Ching FY, Chan FH, Chen LH, Garcia-Barcelo M, Sham PC

Neuropsychiatric Disease and Treatment 2017, 13:1071-1080

Published Date: 11 April 2017

Metabolic screening and its impact in children with non-syndromic intellectual disability

Ali YF, EL-Morshedy S, Elsayed RM, EL-sherbini AM, El-Sayed SAM, Abdrahman NIA, Imam AA

Neuropsychiatric Disease and Treatment 2017, 13:1065-1070

Published Date: 19 April 2017

Clinical and biochemical study of D-serine metabolism among schizophrenia patients

El-Tallawy HN, Saleem TH, El-Ebidi AMA, Hassan MH, Gabra RH, Farghaly WMA, Abo El-Maali N, Sherkawy HS

Neuropsychiatric Disease and Treatment 2017, 13:1057-1063

Published Date: 10 April 2017

Pathogenic beliefs among patients with depressive disorders

Neelapaijit A, Wongpakaran T, Wongpakaran N, Thongpibul K

Neuropsychiatric Disease and Treatment 2017, 13:1047-1055

Published Date: 10 April 2017

Hashimoto encephalopathy with high plasma monoamine metabolite levels: a case report

Horikoshi S, Miura I, Kunii Y, Asano S, Kanno-Nozaki K, Mashiko H, Yabe H

Neuropsychiatric Disease and Treatment 2017, 13:1043-1045

Published Date: 7 April 2017

Quetiapine monotherapy versus placebo in the treatment of children and adolescents with bipolar depression: a systematic review and meta-analysis

Maneeton B, Putthisri S, Maneeton N, Woottiluk P, Suttajit S, Charnsil C, Srisurapanont M

Neuropsychiatric Disease and Treatment 2017, 13:1023-1032

Published Date: 4 April 2017

Relationship between hypnosis and personality trait in participants with high or low hypnotic susceptibility

Zhang Y, Wang Y, Shen C, Ye Y, Shen S, Zhang B, Wang J, Chen W, Wang W

Neuropsychiatric Disease and Treatment 2017, 13:1007-1012

Published Date: 3 April 2017

An Internet-based program for depressive symptoms using human and automated support: a randomized controlled trial

Mira A, Bretón-López J, García-Palacios A, Quero S, Baños RM, Botella C

Neuropsychiatric Disease and Treatment 2017, 13:987-1006

Published Date: 31 March 2017

Punding following posterior cerebral artery infarction: a case report and review of literature

Lin CI, Lin YC, Lien WC, Hsieh PC, Lin SH, Kuan TS

Neuropsychiatric Disease and Treatment 2017, 13:981-985

Published Date: 31 March 2017

Twelve-week physical exercise does not have a long-lasting effect on kynurenines in plasma of depressed patients

Millischer V, Erhardt S, Ekblom Ö, Forsell Y, Lavebratt C

Neuropsychiatric Disease and Treatment 2017, 13:967-972

Published Date: 31 March 2017

Sleep apnea and the subsequent risk of Parkinson’s disease: a 3-year nationwide population-based study

Chou PS, Lai CL, Chou YH, Chang WP

Neuropsychiatric Disease and Treatment 2017, 13:959-965

Published Date: 30 March 2017

Comparing the ability of cognitive and affective Theory of Mind in adolescent onset schizophrenia

Li D, Li X, Yu F, Chen X, Zhang L, Li D, Wei Q, Zhang Q, Zhu C, Wang K

Neuropsychiatric Disease and Treatment 2017, 13:937-945

Published Date: 27 March 2017

Compound porcine cerebroside and ganglioside injection attenuates cerebral ischemia–reperfusion injury in rats by targeting multiple cellular processes

Wang M, Zhang Y, Feng L, Zheng J, Fan S, Liu J, Yang N, Liu Y, Zuo P

Neuropsychiatric Disease and Treatment 2017, 13:927-935

Published Date: 27 March 2017

The Maugeri Stress Index – reduced form: a questionnaire for job stress assessment

Massidda D, Giorgi I, Vidotto G, Tringali S, Imbriani M, Baiardi P, Bertolotti G

Neuropsychiatric Disease and Treatment 2017, 13:917-926

Published Date: 24 March 2017

Illness denial questionnaire for patients and caregivers

Rossi Ferrario S, Giorgi I, Baiardi P, Giuntoli L, Balestroni G, Cerutti P, Manera M, Gabanelli P, Solara V, Fornara R, Luisetti M, Omarini P, Omarini G, Vidotto G

Neuropsychiatric Disease and Treatment 2017, 13:909-916

Published Date: 23 March 2017

Association study of MIF promoter polymorphisms with suicide completers in the Japanese population

Shimmyo N, Hishimoto A, Otsuka I, Okazaki S, Boku S, Mouri K, Horai T, Takahashi M, Ueno Y, Shirakawa O, Sora I

Neuropsychiatric Disease and Treatment 2017, 13:899-908

Published Date: 22 March 2017

Dynamic balance in children with attention-deficit hyperactivity disorder and its relationship with cognitive functions and cerebellum

Goetz M, Schwabova JP, Hlavka Z, Ptacek R, Surman CBH

Neuropsychiatric Disease and Treatment 2017, 13:873-880

Published Date: 21 March 2017

Antistress effects of Kampo medicine "Yokukansan" via regulation of orexin secretion

Katahira H, Sunagawa M, Watanabe D, Kanada Y, Katayama A, Yamauchi R, Takashima M, Ishikawa S, Hisamitsu T

Neuropsychiatric Disease and Treatment 2017, 13:863-872

Published Date: 20 March 2017

Long-term efficacy and safety of lamotrigine for all types of bipolar disorder

Watanabe Y, Hongo S

Neuropsychiatric Disease and Treatment 2017, 13:843-854

Published Date: 20 March 2017

Some children with autism have latent social skills that can be tested

Hrdlicka M, Urbanek T, Vacova M, Beranova S, Dudova I

Neuropsychiatric Disease and Treatment 2017, 13:827-833

Published Date: 16 March 2017

Neuropsychiatric symptoms in untreated Parkinson’s disease

Szatmari S, Illigens BM, Siepmann T, Pinter A, Takats A, Bereczki D

Neuropsychiatric Disease and Treatment 2017, 13:815-826

Published Date: 16 March 2017

Daily activity level improvement with antidepressant medications predicts long-term clinical outcomes in outpatients with major depressive disorder

Jha MK, Teer RB, Minhajuddin A, Greer TL, Rush AJ, Trivedi MH

Neuropsychiatric Disease and Treatment 2017, 13:803-813

Published Date: 15 March 2017

Validation and cultural adaptation of the Arabic versions of the Mini–Mental Status Examination – 2 and Mini-Cog test

Albanna M, Yehya A, Khairi A, Dafeeah E, Elhadi A, Rezgui L, Al Kahlout S, Yousif A, Uthman B, Al-Amin H

Neuropsychiatric Disease and Treatment 2017, 13:793-801

Published Date: 14 March 2017

Attention-deficit hyperactivity disorder in elementary school students in Shantou, China: prevalence, subtypes, and influencing factors

Huang Y, Zheng S, Xu C, Lin K, Wu K, Zheng M, Zhang J, Xu H

Neuropsychiatric Disease and Treatment 2017, 13:785-792

Published Date: 14 March 2017

Work–family conflict as a mediator between occupational stress and psychological health among mental health nurses in Japan

Sugawara N, Danjo K, Furukori H, Sato Y, Tomita T, Fujii A, Nakagami T, Kitaoka K, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2017, 13:779-784

Published Date: 13 March 2017

Preliminary evaluation of a “formulation-driven cognitive behavioral guided self-help (fCBT-GSH)” for crisis and transitional case management clients

Naeem F, Johal RK, Mckenna C, Calancie O, Munshi T, Hassan T, Nasar A, Ayub M

Neuropsychiatric Disease and Treatment 2017, 13:769-774

Published Date: 10 March 2017

Confirmation of the factorial structure of the Japanese short version of the TEMPS-A in psychiatric patients and general adults [Corrigendum]

Nakato Y, Inoue T, Nakagawa S, Kitaichi Y, Kameyama R, Wakatsuki Y, Kitagawa K, Omiya Y, Kusumi I

Neuropsychiatric Disease and Treatment 2017, 13:767-768

Published Date: 9 March 2017

Lithium in late-life mania: a systematic review

De Fazio P, Gaetano R, Caroleo M, Pavia M, De Sarro G, Fagiolini A, Segura-Garcia C

Neuropsychiatric Disease and Treatment 2017, 13:755-766

Published Date: 9 March 2017

Monitoring brain multiparameters and hypothermia in severe traumatic brain injury

Vasconcelos FR, Andrade AF, Teixeira MJ, Paiva WS

Neuropsychiatric Disease and Treatment 2017, 13:721-722

Published Date: 8 March 2017

Prevalence of dementia in Egypt: a systematic review

Elshahidi MH, Elhadidi MA, Sharaqi AA, Mostafa A, Elzhery MA

Neuropsychiatric Disease and Treatment 2017, 13:715-720

Published Date: 6 March 2017

New opinion on the subtypes of poststroke depression in Chinese stroke survivors

Yue Y, Liu R, Cao Y, Wu Y, Zhang S, Li H, Zhu J, Jiang W, Wu A, Yuan Y

Neuropsychiatric Disease and Treatment 2017, 13:707-713

Published Date: 6 March 2017

Influence of CFH gene on symptom severity of schizophrenia

Zhang C, Lv QY, Fan WX, Tang W, Yi ZH

Neuropsychiatric Disease and Treatment 2017, 13:697-706

Published Date: 2 March 2017

Trend, characteristics, and pharmacotherapy of adults diagnosed with attention-deficit/hyperactivity disorder: a nationwide survey in Taiwan

Cheng YS, Shyu YC, Lee SY, Yuan SS, Yang CJ, Yang KC, Lee TL, Wang LJ

Neuropsychiatric Disease and Treatment 2017, 13:643-651

Published Date: 1 March 2017

Screening for bipolar disorder among migraineurs: the impact of migraine–bipolar disorder comorbidity on disease characteristics

Kivilcim Y, Altintas M, Domac FM, Erzincan E, Gülec H

Neuropsychiatric Disease and Treatment 2017, 13:631-641

Published Date: 1 March 2017

Metabolic profile at first-time schizophrenia diagnosis: a population-based cross-sectional study

Horsdal HT, Benros ME, Köhler-Forsberg O, Krogh J, Gasse C

Neuropsychiatric Disease and Treatment 2017, 13:621-630

Published Date: 28 February 2017

Quality of life in children and adolescents with obsessive–compulsive disorder: a systematic review and meta-analysis

Coluccia A, Ferretti F, Fagiolini A, Pozza A

Neuropsychiatric Disease and Treatment 2017, 13:597-608

Published Date: 24 February 2017

Contemplating stem cell therapy for epilepsy-induced neuropsychiatric symptoms

Rao G, Mashkouri S, Aum D, Marcet P, Borlongan CV

Neuropsychiatric Disease and Treatment 2017, 13:585-596

Published Date: 23 February 2017

Prefrontal cortex activation during neuropsychological tasks might predict response to pharmacotherapy in patients with obsessive–compulsive disorder

Takeda T, Sumitani S, Hamatani S, Yokose Y, Shikata M, Ohmori T

Neuropsychiatric Disease and Treatment 2017, 13:577-583

Published Date: 23 February 2017

Quality of life, self-stigma, and hope in schizophrenia spectrum disorders: a cross-sectional study

Vrbova K, Prasko J, Ociskova M, Kamaradova D, Marackova M, Holubova M, Grambal A, Slepecky M, Latalova K

Neuropsychiatric Disease and Treatment 2017, 13:567-576

Published Date: 23 February 2017

Gender differences in the association between HTR2C gene variants and suicidal behavior in a Mexican population: a case–control study

Molina-Guzman G, González-Castro TB, Hernández-Díaz Y, Tovilla-Zárate CA, Juárez-Rojop IE, Guzmán-Priego CG, Genis A, Pool García S, López-Narvaez ML, Rodriguez-Perez JM

Neuropsychiatric Disease and Treatment 2017, 13:559-566

Published Date: 22 February 2017

Assessment of poststroke mania and diagnosis

Shoaib M, Aadil M

Neuropsychiatric Disease and Treatment 2017, 13:557-558

Published Date: 21 February 2017

Validation of the Revised Illness Perception Questionnaire in Turkish epilepsy patients and the effects of earthquake experience on perception of disease

Keskin Güler S, Güler S, Gökçe Çokal B, Gunes N, Yon Mİ, Yoldas TK

Neuropsychiatric Disease and Treatment 2017, 13:551-556

Published Date: 21 February 2017

Analysis concerning nutritional behaviors in the context of the risk of orthorexia

Olejniczak D, Bugajec D, Panczyk M, Brytek-Matera A, Religioni U, Czerw A, Grąbczewska A, Juszczyk G, Jabłkowska-Górecka K, Staniszewska A

Neuropsychiatric Disease and Treatment 2017, 13:543-550

Published Date: 21 February 2017

Gene expression-based biological test for major depressive disorder: an advanced study

Watanabe S, Numata S, Iga J, Kinoshita M, Umehara H, Ishii K, Ohmori T

Neuropsychiatric Disease and Treatment 2017, 13:535-541

Published Date: 21 February 2017

Association of carotid atherosclerosis and recurrent cerebral infarction in the Chinese population: a meta-analysis

Liu J, Zhu Y, Wu Y, Liu Y, Teng Z, Hao Y

Neuropsychiatric Disease and Treatment 2017, 13:527-533

Published Date: 20 February 2017

Efficacy and tolerability of escitalopram in treatment of major depressive disorder with anxiety symptoms: a 24-week, open-label, prospective study in Chinese population

Jiang KD, Li LJ, Wang XY, Fang MS, Shi JF, Cao QY, He JC, Wang JN, Tan WH, Hu CL

Neuropsychiatric Disease and Treatment 2017, 13:515-526

Published Date: 17 February 2017

Abnormal resting-state brain activities in patients with first-episode obsessive-compulsive disorder

Niu Q, Yang L, Song X, Chu C, Liu H, Zhang L, Li Y, Zhang X, Cheng J, Li Y

Neuropsychiatric Disease and Treatment 2017, 13:507-513

Published Date: 16 February 2017

Blood pressure and anthropometry in children treated with stimulants: a longitudinal cohort study with an individual approach

Landgren M, Nasic S, Johnson M, Lövoll T, Holmgren D, Fernell E

Neuropsychiatric Disease and Treatment 2017, 13:499-506

Published Date: 16 February 2017

Efficacy and safety of Ginkgo biloba standardized extract in the treatment of vascular cognitive impairment: a randomized, double-blind, placebo-controlled clinical trial

Demarin V, Bašić Kes V, Trkanjec Z, Budišić M, Bošnjak Pašić M, Črnac P, Budinčević H

Neuropsychiatric Disease and Treatment 2017, 13:483-490

Published Date: 16 February 2017

Associations among depressive symptoms, childhood abuse, neuroticism, and adult stressful life events in the general adult population

Ono K, Takaesu Y, Nakai Y, Shimura A, Ono Y, Murakoshi A, Matsumoto Y, Tanabe H, Kusumi I, Inoue T

Neuropsychiatric Disease and Treatment 2017, 13:477-482

Published Date: 15 February 2017

Delirium after a traumatic brain injury: predictors and symptom patterns

Maneewong J, Maneeton B, Maneeton N, Vaniyapong T, Traisathit P, Sricharoen N, Srisurapanont M

Neuropsychiatric Disease and Treatment 2017, 13:459-465

Published Date: 14 February 2017

Caregiver perspective on pediatric attention-deficit/hyperactivity disorder: medication satisfaction and symptom control

Fridman M, Banaschewski T, Sikirica V, Quintero J, Erder MH, Chen KS

Neuropsychiatric Disease and Treatment 2017, 13:443-455

Published Date: 13 February 2017

Influence of fluvoxamine on plasma interleukin-6 or clinical improvement in patients with major depressive disorder

Yoshimura R, Katsuki A, Atake K, Hori H, Igata R, Konishi Y

Neuropsychiatric Disease and Treatment 2017, 13:437-441

Published Date: 14 February 2017

Abnormal whole-brain functional connectivity in patients with primary insomnia

Li C, Dong M, Yin Y, Hua K, Fu S, Jiang G

Neuropsychiatric Disease and Treatment 2017, 13:427-435

Published Date: 13 February 2017

The dynamic relationship between emotional and physical states: an observational study of personal health records

Lee YS, Jung WM, Jang H, Kim S, Chung SY, Chae Y

Neuropsychiatric Disease and Treatment 2017, 13:411-419

Published Date: 9 February 2017

Resting-state functional connectivity changes within the default mode network and the salience network after antipsychotic treatment in early-phase schizophrenia

Wang Y, Tang W, Fan X, Zhang J, Geng D, Jiang K, Zhu D, Song Z, Xiao Z, Liu D

Neuropsychiatric Disease and Treatment 2017, 13:397-406

Published Date: 7 February 2017

Risk assessment of aggressive behavior in Chinese patients with schizophrenia by fMRI and COMT gene

Tang X, Jin J, Tang Y, Cao J, Huang J

Neuropsychiatric Disease and Treatment 2017, 13:387-395

Published Date: 7 February 2017

Factors associated with caregiver burden among pharmacotherapy-treated children/adolescents with ADHD in the Caregiver Perspective on Pediatric ADHD survey in Europe

Fridman M, Banaschewski T, Sikirica V, Quintero J, Erder MH, Chen KS

Neuropsychiatric Disease and Treatment 2017, 13:373-386

Published Date: 7 February 2017

Use of transcranial direct current stimulation for the treatment of auditory hallucinations of schizophrenia – a systematic review

Pondé PH, de Sena EP, Camprodon JA, Araújo AN, Neto MF, DiBiasi M, Baptista AF, Moura LMVR, Cosmo C

Neuropsychiatric Disease and Treatment 2017, 13:347-355

Published Date: 1 February 2017

N-Methyl-D-aspartate receptor antibody could be a cause of catatonic symptoms in psychiatric patients: case reports and methods for detection

Tsutsui K, Kanbayashi T, Takaki M, Omori Y, Imai Y, Nishino S, Tanaka K, Shimizu T

Neuropsychiatric Disease and Treatment 2017, 13:339-345

Published Date: 8 February 2017

Sexual dimorphism in Parkinson’s disease: differences in clinical manifestations, quality of life and psychosocial functioning between males and females

Farhadi F, Vosoughi K, Shahidi GA, Delbari A, Lökk J, Fereshtehnejad SM

Neuropsychiatric Disease and Treatment 2017, 13:329-338

Published Date: 1 February 2017

The parental bonding in families of adolescents with anorexia: attachment representations between parents and offspring

Balottin L, Mannarini S, Rossi M, Rossi G, Balottin U

Neuropsychiatric Disease and Treatment 2017, 13:319-327

Published Date: 1 February 2017

The spectrum of psychosis in multiple sclerosis: a clinical case series

Gilberthorpe TG, O'Connell KE, Carolan A, Silber E, Brex PA, Sibtain NA, David AS

Neuropsychiatric Disease and Treatment 2017, 13:303-318

Published Date: 1 February 2017

The relationship between childhood trauma and adult psychosis in a UK Early Intervention Service: results of a retrospective case note study

Reeder FD, Hussain N, Rhouma A, Haddad PM, Munshi T, Naeem F, Khachatryan D, Chaudhry IB

Neuropsychiatric Disease and Treatment 2017, 13:269-273

Published Date: 8 February 2017

Role of prediabetes in stroke

Mijajlović MD, Aleksić VM, Šternić NM, Mirković MM, Bornstein NM

Neuropsychiatric Disease and Treatment 2017, 13:259-267

Published Date: 2 February 2017

Visual–spatial training efficacy in children affected by migraine without aura: a multicenter study

Precenzano F, Ruberto M, Parisi L, Salerno M, Maltese A, Gallai B, Marotta R, Lavano SM, Lavano F, Roccella M

Neuropsychiatric Disease and Treatment 2017, 13:253-258

Published Date: 27 January 2017

Efficacy of a short cognitive training program in patients with multiple sclerosis

Pérez-Martín MY, González-Platas M, Eguía-del Rio P, Croissier-Elías C, Jiménez Sosa A

Neuropsychiatric Disease and Treatment 2017, 13:245-252

Published Date: 3 February 2017

A survey of eMedia-delivered interventions for schizophrenia used in randomized controlled trials

Naeem F, Munshi T, Xiang S, Yang M, Shokraneh F, Syed Y, Ayub M, Adams CE, Farooq S

Neuropsychiatric Disease and Treatment 2017, 13:233-243

Published Date: 27 January 2017

Construct validity of the Depression and Somatic Symptoms Scale: evaluation by Mokken scale analysis

Chou YH, Lee CP, Liu CY, Hung CI

Neuropsychiatric Disease and Treatment 2017, 13:205-211

Published Date: 23 January 2017

Switching bipolar disorder patients treated with clozapine to another antipsychotic medication: a mirror image study

Ifteni P, Teodorescu A, Moga MA, Pascu AM, Miclaus RS

Neuropsychiatric Disease and Treatment 2017, 13:201-204

Published Date: 23 January 2017

A possible role of the Infant/Toddler Sensory Profile in screening for autism: a proof-of-concept study in the specific sample of prematurely born children with birth weights <1,500 g

Beranova S, Stoklasa J, Dudova I, Markova D, Kasparova M, Zemankova J, Urbanek T, Talasek T, Luukka P, Hrdlicka M

Neuropsychiatric Disease and Treatment 2017, 13:191-200

Published Date: 23 January 2017

A preliminary study of Patient Dignity Inventory validation among patients hospitalized in an acute psychiatric ward

Di Lorenzo R, Cabri G, Carretti E, Galli G, Giambalvo N, Rioli G, Saraceni S, Spiga G, Del Giovane C, Ferri P

Neuropsychiatric Disease and Treatment 2017, 13:177-190

Published Date: 23 January 2017

Neuroleptic malignant syndrome: an easily overlooked neurologic emergency

Oruch R, Pryme IF, Engelsen BA, Lund A

Neuropsychiatric Disease and Treatment 2017, 13:161-175

Published Date: 16 January 2017

Evaluation of the risk factors of depressive disorders comorbid with obstructive sleep apnea

Cai LQ, Xu LY, Wei LL, Sun Y, Chen W

Neuropsychiatric Disease and Treatment 2017, 13:155-159

Published Date: 16 January 2017

Effects of paliperidone extended release on hostility among Thai patients with schizophrenia

Jariyavilas A, Thavichachart N, Kongsakon R, Chantakarn S, Arunpongpaisal S, Chantarasak V, Jaroensook P, Kittiwattanagul K, Nerapusee O

Neuropsychiatric Disease and Treatment 2017, 13:141-146

Published Date: 12 January 2017

Association of peripheral neuropathy with sleep-related breathing disorders in myotonic dystrophies

Banach M, Antczak J, Rola R

Neuropsychiatric Disease and Treatment 2017, 13:133-140

Published Date: 12 January 2017

Quality of life in cervical dystonia after treatment with botulinum toxin A: a 24-week prospective study

Kongsaengdao S, Maneeton B, Maneeton N

Neuropsychiatric Disease and Treatment 2017, 13:127-132

Published Date: 10 January 2017

Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial

Kishi T, Matsuda Y, Matsunaga S, Moriwaki M, Otake Y, Akamatsu K, Okochi T, Hirano S, Funahashi T, Okuda M, Tabuse H, Fujita K, Iwata N

Neuropsychiatric Disease and Treatment 2017, 13:117-125

Published Date: 6 January 2017

Cognitive profiles in bilingual children born to immigrant parents and Italian monolingual native children with specific learning disorders

Riva A, Nacinovich R, Bertuletti N, Montrasi V, Marchetti S, Neri F, Bomba M

Neuropsychiatric Disease and Treatment 2017, 13:109-116

Published Date: 30 December 2016

Risperidone improves interpersonal perception and executive function in patients with schizophrenia

Zhou Z, Zhu Y, Wang J, Zhu H

Neuropsychiatric Disease and Treatment 2017, 13:101-107

Published Date: 28 December 2016

Alterations of white matter fractional anisotropy in unmedicated obsessive–compulsive disorder

Tao J, Wang XL, Zhong ZY, Han HY, Liu S, Wen SL, Guan NH, Li LJ

Neuropsychiatric Disease and Treatment 2017, 13:69-76

Published Date: 28 December 2016

A biopsychological review of gambling disorder

Quintero GC

Neuropsychiatric Disease and Treatment 2017, 13:51-60

Published Date: 23 December 2016

Detailed course of depressive symptoms and risk for developing depression in late adolescents with subthreshold depression: a cohort study

Jinnin R, Okamoto Y, Takagaki K, Nishiyama Y, Yamamura T, Okamoto Y, Miyake Y, Takebayashi Y, Tanaka K, Sugiura Y, Shimoda H, Kawakami N, Furukawa TA, Yamawaki S

Neuropsychiatric Disease and Treatment 2017, 13:25-33

Published Date: 22 December 2016

Temperament, personality, and treatment outcome in major depression: a 6-month preliminary prospective study

Kudo Y, Nakagawa A, Wake T, Ishikawa N, Kurata C, Nakahara M, Nojima T, Mimura M

Neuropsychiatric Disease and Treatment 2017, 13:17-24

Published Date: 19 December 2016

Pioglitazone could induce remission in major depression: a meta-analysis

Colle R, de Larminat D, Rotenberg S, Hozer F, Hardy P, Verstuyft C, Fève B, Corruble E

Neuropsychiatric Disease and Treatment 2017, 13:9-16

Published Date: 19 December 2016

Minocycline and celecoxib as adjunctive treatments for bipolar depression: a study protocol for a multicenter factorial design randomized controlled trial

Husain MI, Chaudhry IB, Hamirani MM, Minhas FA, Kazmi A, Hodsoll J, Haddad PM, Deakin JFW, Husain N, Young AH

Neuropsychiatric Disease and Treatment 2017, 13:1-8

Published Date: 19 December 2016